Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baxter International (DE:BTL)
FRANKFURT:BTL
Baxter International (BTL) Stock Price & Analysis
2 Followers
BTL Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€29.01 - €43.23
Previous Close€32.25
Volume280.00
Average Volume (3M)116.00
Market Cap
€16.52B
Enterprise Value€26.78B
Total Cash (Recent Filing)$3.19B
Total Debt (Recent Filing)$14.24B
Price to Earnings (P/E)N/A
Beta0.46
Next Earnings
Jul 25, 2024EPS Estimate
€0.61Next Dividend Ex-Date
May 31, 2024Dividend Yield3.29%
Share Statistics
EPS (TTM)N/A
Shares Outstanding509,580,190
10 Day Avg. Volume109
30 Day Avg. Volume116
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-4.29
Price to Sales (P/S)4.38
Price to Cash Flow (P/CF)8.50
P/FCF Ratio10.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.81
Enterprise Value/Gross Profit5.38
Enterprise Value/Ebitda30.64
Forecast
1Y Price Target
€40.75Price Target Upside26.35% Upside
Rating ConsensusHold
Number of Analyst Covering8
Baxter International News
PremiumCompany Announcements
Baxter International’s Governance and Executive Decisions at 2024 Meeting
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceThe company beat Stifel/Consensus revenue and EPS expectations.
Product ApprovalFDA cleared BAX’s Novum IQ large volume pump (LVP), which was excluded from BAX’s 2024 guidance, indicating potential unanticipated revenue.
Strategic DivestitureAnalyst recommends a sale of KidneyCo as it likely offers better value upfront for BAX shareholders compared to a spin-off.
Bears Say
Corporate RestructuringThe Kidney Care business, set to be spun-off, was a significant outperformance driver, suggesting a possibly more-dilutive RemainCo impact once separated.
Operational PerformanceHill-Rom Healthcare Systems & Technologies integration struggles continued with the business declining 9% in the quarter.
Product CompetitionAlaris was approved approximately 7 months ahead of Novum IQ, possibly reducing the anticipated upside for BAX.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
29.22% Other Institutional Investors
70.78% Public Companies and
Individual Investors
BTL FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest stock price was €29.01 and its highest was €43.23 in the past 12 months.
What is Baxter International’s market cap?
Currently, no data Available
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is Jul 25, 2024 which is in 66 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on May 02, 2024. The company reported €0.601 earnings per share for the quarter, beating the consensus estimate of €0.561 by €0.04.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of €0.27 which represents an annual dividend yield of 3.29%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is €0.61.
How many shares outstanding does Baxter International have?
Currently, no data Available
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of €0.601 in its last earnings report, beating expectations of €0.561. Following the earnings report the stock price went down -1.516%.
Which hedge fund is a major shareholder of Baxter International?
Among the largest hedge funds holding Baxter International’s share is Dodge & Cox. It holds Baxter International’s shares valued at 1B.
---
Baxter International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€40.75 (26.35% Upside)
€40.75 (26.35% Upside)
Blogger Sentiment
Bullish
DE:BTL Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.16%
12-Months-Change
Fundamentals
Return on Equity
-0.54%
Trailing 12-Months
Asset Growth
-1.78%
Trailing 12-Months
Company Description
Baxter International
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
---
BTL Company Deck
---
BTL Earnings Call
Q1 2024
0:00 / 0:00
---
BTL Net sales Breakdown
33.83% Medical Products and Therapies
30.06% Kidney Care
20.34% Healthcare Systems and Technologies
15.18% Pharmaceuticals
0.59% Other
---
BTL Stock 12 Month Forecast
Average Price Target
€40.75
▲(26.35% Upside)
Technical Analysis
Best Analysts Covering BTL
1 Year
1 Year Success Rate
7/20 ratings generated profit
1 Year Average Return
-5.71%
assigned a buy rating 2 months ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 35.00% of your transactions generating a profit, with an average return of -5.71% per trade.
---